Tag: 1 DNA Way

[Through the Glass Door] Roche’s Genentech Talent Acquisition: 20 Questions

Neither Roche Chairman Franz Humer nor CEO Severin Schwan have called me up to ask how I’d handle the talent side of their Genentech acquisition. Perhaps they will, but they’ve also been pretty mum on their plans moving forward for the talent at 1 DNA Way . To save Franz and Severin a long distance phone call charge, here are some questions I’d be answering if I were on point with the talent side of the Genentech project.

Read More